Probiotics in chronic pouchitis: Restoring luminal microbial balance

Gastroenterology

Volumn 119, Issue 2, 2000, Pages 584-586

  Sartor, R B ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AZATHIOPRINE; BISMUTH; BUTYRIC ACID; CIPROFLOXACIN; CLARITHROMYCIN; CORTICOSTEROID; CYCLOSPORIN; GLUTAMINE; MESALAZINE; METRONIDAZOLE; PLACEBO; PROBIOTIC AGENT; RIFAXIMIN; TETRACYCLINE;

ABDOMINAL CRAMP; BIFIDOBACTERIUM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EDITORIAL; ENTERITIS; FEVER; GASTROINTESTINAL HEMORRHAGE; HUMAN; ILEITIS; ILEOANAL ANASTOMOSIS; ILEOSTOMY; ILEUM POUCH; LACTOBACILLUS; PRIORITY JOURNAL; PROCTOCOLECTOMY; RANDOMIZED CONTROLLED TRIAL; STREPTOCOCCUS SALIVARIUS; ULCERATIVE COLITIS;

EID: 0033868407     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2000.9866     Document Type: Article

References (24)

1. J ileal pouch-anal anastomosis for chronic ulcerative colitis: Complications and long-term outcome in 1310 patients
2. Patterns of distribution of endoscopic and histological changes in the ileal reservoir after restorative proctocolectomy for ulcerative colitis. A long-term follow-up study
3. Prospective study of morphologic and functional changes with time in the mucosa of the ileoanal pouch: Functional appraisal using transmucosal potential differences
4. Pouchitis following ileal pouch-anal anastomosis: Definition, pathogenesis, and treatment
5. Pouchitis after ileal pouch-anal anastomosis: A pouchitis disease activity index
6. Medical therapy for induction and maintenance of remission in pouchitis: A systematic review
7. Ileoanal pouch operation: Long-term outcome with or without diverting ileostomy
8. The implications of acute pouchitis on the long-term functional results after restorative proctocolectomy
9. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial
10. Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis
11. Lactobacillus species prevents colitis in interleukin 10 genedeficient mice
12. Continuous feeding of Lactobacillus plantarum attenuates established colitis in interleukin-10 deficient mice (abstr)
13. 27 transgenic rats after antibiotic treatment
14. Probiotics and inflammatory bowel diseases
15. Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis
16. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: A randomised trial
17. Impact on the composition of the faecal flora by a new probiotic preparation: Preliminary data on maintenance treatment of patients with ulcerative colitis
18. Prophylaxis of pouchitis onset with probiotic therapy: A double-blind placebo controlled trial
19. Treatment of refractory 'pouchitis' with prebiotic and probiotic therapy
20. The mechanism of germinated barley foodstuff in attenuating intestinal inflammation in colitis
21. Elevated lL-10 levels in pouch-tissue after probiotic therapy
22. Oral administration of Lactobacillus GG (L. GG) induces an antiinflammatory, TH-2 mediated systemic immune response towards intestinal organisms
23. Fecal beta-D-galactosidase production and Bifidobacteria are decreased in Crohn's disease
24. Microbial factors in the pathogenesis of Crohn's disease, ulcerative colitis and experimental intestinal inflammation